Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

HERNEXEOS vs PORTRAZZA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. HERNEXEOS and PORTRAZZA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

hernexeosportrazza

Rating

72/100
70/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

ZONGERTINIB
NECITUMUMAB

Manufacturer

Boehringer Ingelheim
Eli Lilly Co

Dosage forms

Tablet
Injectable

Drug class

—
—

Boxed warning

None
None

Treats

Non-Small-Cell Lung Carcinoma
Non-Small-Cell Lung Carcinoma

Frequently asked questions

Which is better-rated, Hernexeos or Portrazza?

By our independent rating, Hernexeos scores higher — 3.6 vs 3.5 out of 5 for Portrazza. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Hernexeos and Portrazza?

Hernexeos contains Zongertinib, while Portrazza contains Necitumumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.